The effect of pentoxifylline on haemolysis during cardiopulmonary bypass in open-heart surgery
ACTA CARDIOLOGICA, vol.61, no.1, pp.7-11, 2006 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 61 Issue: 1
- Publication Date: 2006
- Doi Number: 10.2143/ac.61.1.2005134
- Journal Name: ACTA CARDIOLOGICA
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.7-11
- Keywords: pentoxifylline, haemolysis, cardiopulmonary bypass, haemoglobin, haptoglobin, INTERNAL THORACIC ARTERY, RED-CELL DEFORMABILITY, FREE HEMOGLOBIN, INFLAMMATORY RESPONSE, ISCHEMIA-REPERFUSION, LUNG, INHIBITION, ACTIVATION, INJURY
- Akdeniz University Affiliated: Yes
Abstract
Objective - Haemolysis has long been recognized as one of the responses to cardiopulmonary bypass (CPB). Pentoxifylline (PTX), a methylxanthine derivative, has been known for many years for its haemorrheological properties. In this prospective, randomized study, we investigated whether a PTX treatment would reduce the haemolysis during CPB.